• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Depression Affects Two-Year Survival Rates in Head and Neck Cancer Patients

by Amy E. Hamaker • March 5, 2018

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Comment: The significance of this publication is that it improves our understanding of how depressive symptoms, which affect nearly 70% of patients with head and neck cancer, may affect treatment response and survival. The authors found that patients with greater depressive symptoms at the time of treatment planning experienced worse overall survival and were at greater risk for treatment interruptions and poorer therapeutic responses. The article helps to underscore the importance of carefully assessing patients with head and neck cancer preparing to undergo treatment for depressive symptoms to identify those patients at risk for worse long term outcomes. —Andres Bur, MD

You Might Also Like

  • Diagnosing and Treating Depression in Head and Neck Cancer Patients
  • Travel Distance Alone Not Associated with Worsened Two-Year Survival in Patients with Newly Diagnosed Head and Neck Cancer
  • Survival for Advanced Head, Neck Cancer Improvements May Be Related to PET
  • New Immunotherapy Improves Survival Rates in Squamous Cell Carcinoma of the Head and Neck
Explore This Issue
March 2018

Do greater depressive symptoms predict earlier mortality in head and neck cancer patients, particularly when accounting for behavioral (treatment interruption) and biological (treatment response) mediators?

Bottom line: Depression at time of treatment planning appeared to be as important a predictor of two-year survival as traditional clinical prognostic indicators. Effects were partly influenced by the treatment response.

Background: Head and neck cancer patients experience clinical depression rates higher than those of the general population, and they have some of the highest rates among cancer patients. Burgeoning evidence supports the relationship between depression and early mortality among these patients. There are limited pathways by which psychosocial factors, including depression, may affect cancer survival including treatment adherence, biological pathways, and self-care.

Study design: Clinical data review of 134 patients from October 2012 to October 2013 who reported depressive symptomatology at treatment planning.

Setting: University of Louisville, Ky.

Synopsis: Fourteen patients had at least one treatment interruption (three consecutive days without). Interruptions typically occurred early (within the first three weeks) because of acute toxicity (nausea/vomiting), a decline in functional status (falls or stroke), or social factors (legal, transportation issues). Entry depressive symptoms were significantly associated with subsequent treatment interruption as well as with poorer treatment response. The relation between depressive symptoms and survival could not be shown to be mediated by treatment interruption. The only variable associated both with depressive symptoms and overall survival was clinical stage at the time of diagnosis; associations with disease site, age, sex, race, marital status, and pack-years were all non-significant.

Citation: Zimmaro LA, Sephton SE, Siwik CJ, et al. Depressive symptoms predict head and neck cancer survival: examining plausible behavioral and biological pathways. Cancer. 2018;124:1053–1060.

Filed Under: Head and Neck, Literature Reviews Tagged With: cancer survivors, depression, head and neck, mental healthIssue: March 2018

You Might Also Like:

  • Diagnosing and Treating Depression in Head and Neck Cancer Patients
  • Travel Distance Alone Not Associated with Worsened Two-Year Survival in Patients with Newly Diagnosed Head and Neck Cancer
  • Survival for Advanced Head, Neck Cancer Improvements May Be Related to PET
  • New Immunotherapy Improves Survival Rates in Squamous Cell Carcinoma of the Head and Neck

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Have you invented or patented something that betters the field of otolaryngology?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists as Entrepreneurs: Transforming Patient Care And Practice

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Continued Discussion And Engagement Are Essential To How Otolaryngologists Are Championing DEI Initiatives In Medicine

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Leaky Pipes—Time to Focus on Our Foundations
    • You Are Among Friends: The Value Of Being In A Group
    • How To: Full Endoscopic Procedures of Total Parotidectomy
    • How To: Does Intralesional Steroid Injection Effectively Mitigate Vocal Fold Scarring in a Rabbit Model?
    • What Is the Optimal Anticoagulation in HGNS Surgery in Patients with High-Risk Cardiac Comorbidities?

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939